XML 56 R32.htm IDEA: XBRL DOCUMENT v2.4.0.8
Acquisitions and Divestitures - Allocation of Consideration Transferred (Detail) (USD $)
In Millions, unless otherwise specified
Jun. 30, 2013
Uteron Pharma, SA [Member]
Jan. 23, 2013
Uteron Pharma, SA [Member]
Oct. 31, 2012
Actavis Group [Member]
Business Acquisition [Line Items]      
Cash and cash equivalents     $ 110.5
Accounts receivable   1.6 527.9
Inventories     680.1
Other current assets   1.2 286.2
Property and equipment   5.7 763.0
Other long term assets   0.5 16.9
IPR&D intangible assets 250.0 250.0 272.9
Intangible assets     2,268.0
Goodwill   26.4 2,895.2
Current liabilities     (1,396.5)
Current liabilities, excluding current portion of debt   (8.0)  
Long-term deferred tax and other tax liabilities   (82.5) (742.4)
Other long term liabilities   (4.3) (176.0)
Contingent consideration (43.4) (43.4)  
Debt   (5.2) (14.1)
Noncontrolling interests     (21.9)
Net assets acquired   $ 145.0 $ 5,469.8